These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 30055040)

  • 21. Clinical heterogeneity associated with KCNA1 mutations include cataplexy and nonataxic presentations.
    Brownstein CA; Beggs AH; Rodan L; Shi J; Towne MC; Pelletier R; Cao S; Rosenberg PA; Urion DK; Picker J; Tan WH; Agrawal PB
    Neurogenetics; 2016 Jan; 17(1):11-6. PubMed ID: 26395884
    [TBL] [Abstract][Full Text] [Related]  

  • 22. De novo loss- or gain-of-function mutations in KCNA2 cause epileptic encephalopathy.
    Syrbe S; Hedrich UBS; Riesch E; Djémié T; Müller S; Møller RS; Maher B; Hernandez-Hernandez L; Synofzik M; Caglayan HS; Arslan M; Serratosa JM; Nothnagel M; May P; Krause R; Löffler H; Detert K; Dorn T; Vogt H; Krämer G; Schöls L; Mullis PE; Linnankivi T; Lehesjoki AE; Sterbova K; Craiu DC; Hoffman-Zacharska D; Korff CM; Weber YG; Steinlin M; Gallati S; Bertsche A; Bernhard MK; Merkenschlager A; Kiess W; ; Gonzalez M; Züchner S; Palotie A; Suls A; De Jonghe P; Helbig I; Biskup S; Wolff M; Maljevic S; Schüle R; Sisodiya SM; Weckhuysen S; Lerche H; Lemke JR
    Nat Genet; 2015 Apr; 47(4):393-399. PubMed ID: 25751627
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Distinct epilepsy phenotypes and response to drugs in KCNA1 gain- and loss-of function variants.
    Miceli F; Guerrini R; Nappi M; Soldovieri MV; Cellini E; Gurnett CA; Parmeggiani L; Mei D; Taglialatela M
    Epilepsia; 2022 Jan; 63(1):e7-e14. PubMed ID: 34778950
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical spectrum and genotype-phenotype associations of KCNA2-related encephalopathies.
    Masnada S; Hedrich UBS; Gardella E; Schubert J; Kaiwar C; Klee EW; Lanpher BC; Gavrilova RH; Synofzik M; Bast T; Gorman K; King MD; Allen NM; Conroy J; Ben Zeev B; Tzadok M; Korff C; Dubois F; Ramsey K; Narayanan V; Serratosa JM; Giraldez BG; Helbig I; Marsh E; O'Brien M; Bergqvist CA; Binelli A; Porter B; Zaeyen E; Horovitz DD; Wolff M; Marjanovic D; Caglayan HS; Arslan M; Pena SDJ; Sisodiya SM; Balestrini S; Syrbe S; Veggiotti P; Lemke JR; Møller RS; Lerche H; Rubboli G
    Brain; 2017 Sep; 140(9):2337-2354. PubMed ID: 29050392
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Novel mutation in KCNA1 causes episodic ataxia with paroxysmal dyspnea.
    Shook SJ; Mamsa H; Jen JC; Baloh RW; Zhou L
    Muscle Nerve; 2008 Mar; 37(3):399-402. PubMed ID: 17912752
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Experimental validation of in silico predicted KCNA1, KCNA2, KCNA6 and KCNQ2 genes for association studies of peripheral nerve hyperexcitability syndrome in Jack Russell Terriers.
    Van Poucke M; Vanhaesebrouck AE; Peelman LJ; Van Ham L
    Neuromuscul Disord; 2012 Jun; 22(6):558-65. PubMed ID: 22342001
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Novel
    Imbrici P; Conte E; Blunck R; Stregapede F; Liantonio A; Tosi M; D'Adamo MC; De Luca A; Brankovic V; Zanni G
    Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576077
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A de novo KCNA1 Mutation in a Patient with Tetany and Hypomagnesemia.
    van der Wijst J; Konrad M; Verkaart SAJ; Tkaczyk M; Latta F; Altmüller J; Thiele H; Beck B; Schlingmann KP; de Baaij JHF
    Nephron; 2018; 139(4):359-366. PubMed ID: 29791908
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A novel KCNA1 mutation identified in an Italian family affected by episodic ataxia type 1.
    Imbrici P; Gualandi F; D'Adamo MC; Masieri MT; Cudia P; De Grandis D; Mannucci R; Nicoletti I; Tucker SJ; Ferlini A; Pessia M
    Neuroscience; 2008 Dec; 157(3):577-87. PubMed ID: 18926884
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A novel KCNA1 mutation in a family with episodic ataxia and malignant hyperthermia.
    Mestre TA; Manole A; MacDonald H; Riazi S; Kraeva N; Hanna MG; Lang AE; Männikkö R; Yoon G
    Neurogenetics; 2016 Oct; 17(4):245-249. PubMed ID: 27271339
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical, genetic, and expression studies of mutations in the potassium channel gene KCNA1 reveal new phenotypic variability.
    Eunson LH; Rea R; Zuberi SM; Youroukos S; Panayiotopoulos CP; Liguori R; Avoni P; McWilliam RC; Stephenson JB; Hanna MG; Kullmann DM; Spauschus A
    Ann Neurol; 2000 Oct; 48(4):647-56. PubMed ID: 11026449
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A Common Kinetic Property of Mutations Linked to Episodic Ataxia Type 1 Studied in the Shaker Kv Channel.
    Zhao J; Petitjean D; Haddad GA; Batulan Z; Blunck R
    Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33066705
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Functional analysis of a novel potassium channel (KCNA1) mutation in hereditary myokymia.
    Chen H; von Hehn C; Kaczmarek LK; Ment LR; Pober BR; Hisama FM
    Neurogenetics; 2007 Apr; 8(2):131-5. PubMed ID: 17136396
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Episodic ataxia type 1 mutations affect fast inactivation of K+ channels by a reduction in either subunit surface expression or affinity for inactivation domain.
    Imbrici P; D'Adamo MC; Grottesi A; Biscarini A; Pessia M
    Am J Physiol Cell Physiol; 2011 Jun; 300(6):C1314-22. PubMed ID: 21307345
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The episodic ataxia type 1 mutation I262T alters voltage-dependent gating and disrupts protein biosynthesis of human Kv1.1 potassium channels.
    Chen SH; Fu SJ; Huang JJ; Tang CY
    Sci Rep; 2016 Jan; 6():19378. PubMed ID: 26778656
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Musculoskeletal Features without Ataxia Associated with a Novel de novo Mutation in
    Imbrici P; Accogli A; Blunck R; Altamura C; Iacomino M; D'adamo MC; Allegri A; Pedemonte M; Brolatti N; Vari S; Cataldi M; Capra V; Gustincich S; Zara F; Desaphy JF; Fiorillo C
    Biomedicines; 2021 Jan; 9(1):. PubMed ID: 33466780
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical, genetic, neurophysiological and functional study of new mutations in episodic ataxia type 1.
    Tomlinson SE; Rajakulendran S; Tan SV; Graves TD; Bamiou DE; Labrum RW; Burke D; Sue CM; Giunti P; Schorge S; Kullmann DM; Hanna MG
    J Neurol Neurosurg Psychiatry; 2013 Oct; 84(10):1107-12. PubMed ID: 23349320
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ataxia and myoclonic epilepsy due to a heterozygous new mutation in KCNA2: proposal for a new channelopathy.
    Pena SD; Coimbra RL
    Clin Genet; 2015 Feb; 87(2):e1-3. PubMed ID: 25477152
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Kv1.1 and Kv1.2: similar channels, different seizure models.
    Robbins CA; Tempel BL
    Epilepsia; 2012 Jun; 53 Suppl 1():134-41. PubMed ID: 22612818
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A novel mutation in the human voltage-gated potassium channel gene (Kv1.1) associates with episodic ataxia type 1 and sometimes with partial epilepsy.
    Zuberi SM; Eunson LH; Spauschus A; De Silva R; Tolmie J; Wood NW; McWilliam RC; Stephenson JB; Kullmann DM; Hanna MG
    Brain; 1999 May; 122 ( Pt 5)():817-25. PubMed ID: 10355668
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.